PepGen is empowering nucleic acid therapeutics to go the distance.
Pepgen has raised €95M across 1 funding round from 10 investors, most recently a round in Aug 2021. Based in Oxford, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-08-05 | Other | €95M |
| Adage Capital Management,CureDuchenne Ventures,Deerfield Management Company,Gray’s Creek Capital Partners,Laurion Capital Management,Oxford Sciences Innovation+4 more |
| View deal → |
